One More Study Shows PrEP Doesn’t Lead to Riskier Sex
PrEP was approved in 2012 as an HIV prevention tool that can reduce the risk of transmission by more than 90% if used correctly. However, the antiretroviral has remained controversial, and sparsely used, in no small part because of concerns that it will lead to sexual risk bingeing.
'Quad' Is As Effective As Older ARV Options, With Fewer Side Effects
The once-daily combination therapy Stribild,aka: the “Quad” because it contains 4 anitretrovirals, is just as effective as both Atripla therapy & a Reyataz plus Truvada combination. Plus, Stribild is far less likely to give you those crazy dreams, among other psychiatric side effects.
For more info, click here.
New HIV Care Guidelines
Now that antivirals have succeeded in giving a normal life span to many people with HIV, IDSA has urged clinicians to focus their energies outside of the virus and back to primary care.
“In many HIV practices now, 80% of patients with HIV infection have the virus under control. This means that primary care physicians need a better grasp of the impact HIV care has on routine health care. Doctors need to tell their HIV-infected patients, Your HIV disease is controlled, and we need to think about the rest of you.”
—Judith A. Aberg, MD, lead author of the new guidelines.
When Choosing Your First ARV Regimen, Please Note:
The HIV antiretroviral Sustiva (efavirenz), part of triple-therapy combo ATRIPLA, doubles the rate of suicidality—suicidal thoughts and behaviors—among those starting therapy for the first time. For more information, click here.
In a new report, the French health ministry made recommendations on HIV treatment, includingthe promotion of a “combined prevention” that associates behavioral measures, testing strategies and the adoption of antiretroviral (ARV) treatment for all people living with the virus in France.
PEP: In Case of Emergency
Post-exposure prophylaxis can stop HIV, but only if you and your health care providers know about it. Unfortunately, this still seems to be a big problem in the medical community at large….
This POZ exclusive asks: What’s the hold-up with PEP? How accessible is it? Where is it, and how can you be proactive about acquiring it?
Good News: Booze Doesn’t Affect Treatment Failure or CD4 Count!
Although, heavy drinkers are more likely to interrupt their antiretroviral (ARV) regimen.
Click here to read our aidsmap summary.
AS OF NOW: Nearly 10 Million People Worldwide Have ARV Access
The numbers of people accessing antiretroviral therapy increased by 1.6 million from 2011 to 2012.
Here’s some info on UNAIDS statement regarding the biggest year on year increase of ARV access in AIDS history.